Lung and heart-lung transplantation in children

Pediatric Pulmonology

Volumn 23, Issue 1, 1997, Pages 39-48

  Noyes, Blakeslee E ^a,c   Kurland, Geoffrey ^b   Orenstein, David M ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c Cardinal Glennon Hospital   (United States)

Author keywords

bronchio litis obliterans; complications; heart lung transplantation; indications; lung transplantation; outcome; pediatric; survival

Indexed keywords

ARTICLE; BRONCHIOLITIS; CHILD; CONGENITAL HEART DISEASE; CYSTIC FIBROSIS; EISENMENGER COMPLEX; GRAFT VERSUS HOST REACTION; HEART LUNG TRANSPLANTATION; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SURGICAL TECHNIQUE; SURVIVAL; TREATMENT OUTCOME;

CHILD; CYSTIC FIBROSIS; EISENMENGER COMPLEX; GRAFT REJECTION; HEART-LUNG TRANSPLANTATION; HUMANS; HYPERTENSION, PULMONARY; LUNG DISEASES, INTERSTITIAL; LUNG TRANSPLANTATION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; SURVIVAL RATE;

EID: 0031016346     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199701)23:1<39::AID-PPUL5>3.0.CO;2-K     Document Type: Article

References (57)

1. Hardy JD, Webb WR, Dalton ML, Walker GR. Lung homotrans-plantation in man. JAMA. 1963; 186:99-108.
2. Reitz BA, Wallwork JL, Hunt SA, Pennock JL, Billingham ME, Oyer PE, Stinson EB, Shumway NE. Heart-lung transplantation. N Engl J Med. 1982: 306:557-564.
3. Griffith B, Hardesty R, Trento A, Paradis IL, Duquesnoy RJ, Zeevi A, Dauber JH, Dummer JS, Thompson ME, Gryzan S, Bahnson HT. Heart-lung transplantation: Lessons learned and future hopes. Ann Thorac Surg. 1987; 43:6-16.
4. Toronto Lung Transplant Group. Unilateral lung transplantation for pulmonary fibrosis. N Engl J Med. 1986; 314:1140-1145.
5. Hosenpud JD, Novick RJ, Breen TJ, Berkeley B, Daily OP. The Registry of the International Society for Heart and Lung Transplantation: Twelth Official Report-1995. J Heart Lung Transplant. 1995; 14:805-815.
6. Starnes VA, Marshall SE, Lewiston NJ, Theodore J, Stinson EB, Shumway NE. Heart-lung transplantation in infants, children, and adolescents. J Pediatr Surg. 1991; 26:434-438.
7. Smyth RL, Higenbottam TW, Scott JP, McGoldrick JP, Whitehead B, Helms P, de Leval M, Wallwork J. Early experience of heart/ lung transplantation. Arch Dis Child. 1989; 64:1225-1229.
8. Noyes BE, Kurland G, Orenstein DM, Fricker FJ, Armitage JM. Experience with pediatric lung transplantation. J Pediatr. 1994; 124:261-268.
9. Spray TL, Mallory GB, Canter CB, Huddleston CB. Pediatric lung transplantation. J Thorac Cardiovasc Surg. 1994; 107:990-1000.
10. Métras D, Shennib H, Kreitmann B, Camboulives J, Viard L, Carcassonne M, Giudicelli R, Noirclerc M, the Joint Marseille-Montréal Lung Transplant Program. Double-lung transplantation in children: A report of 20 cases. Ann Thorac Surg. 1993; 55:352-357.
11. Fume PA, Egan TM, Westerman JH, Paradowski LJ, Yankaskas JR, Detterbeck FC, Mill MR. Lung transplantation for mechanically ventilated patients. J Heart Lung Transplant 1994; 13:15-21.
12. Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med. 1992; 326:1187-1191.
13. Bridges ND, Mallory GB, Huddleston CB, Canter CE, Sweet SC, Spray TL. Lung transplantation in children and young adults with cardiovascular disease. Ann Thorac Surg. 1995; 59:813-820.
14. Chapelier A, Vouhe P, Macchiarini P, Lenot B, Cerrina J, Leroy Ladurie F, Parquin F, Herve P, Brenot F, Lafont D, Simonneau G, Dartevelle P. Comparative outcome of heart-lung and lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg. 1993; 106:299-307.
15. Nelson JW, Bulter SL, Krieg D, Govan JRW. Virulence factors of Burkholderia cepacia. FEMS Immunol Med Microbiol. 1994; 8:89-98.
16. Snell GI, de Hoyos A, Krajden M, Winton T, Maurer JR. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest. 1993; 103:466-471.
17. Noyes BE, Michaels MG, Kurland G, Armitage J, Orenstein D. Pseudomonas cepacia empyema necessitatis after lung transplantation in two patients with cystic fibrosis. Chest. 1994; 105: 1888-1891.
18. Bisson A, Bonnette P. A new technique for double lung transplantation. J Thorac Cardiovasc Surg. 1992; 103:40-46.
19. Kesten S, de Hoyos A, Chaparro C, Westney G, Winton T, Maurer JR. Aprotinin reduces blood loss in lung transplant recipients. Ann Thorac Surg. 1995; 59:877-879.
20. Jaquiss RDB, Huddleston CB, Spray TL. Use of aprotinin in pediatric lung transplantation. J Heart Lung Transplant. 1995; 14:302-307.
21. Pasque M, Kaiser L, Dressier L, Trulock E, Triantafillou AN, Cooper JD. Single lung transplantation for pulmonary hypertension: Technical aspects and immediate hemodynamic results. J Thorac Cardiovasc Surg. 1992; 103:475-482.
22. Cohen RG, Barr ML, Starnes VA. Pediatric lung transplantation. Semin Pediatr Surg. 1993; 2:279-288.
23. Cohen RG, Barr ML, Schenkel FA, DeMeester TR, Wells WJ, Starnes VA. Living-related donor lobectomy for bilateral lobar transplantation in patients with cystic fibrosis. Ann Thorac Surg. 1994; 57:1423-1427.
24. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporine A and FK506. Immunol Today. 1992: 13:136-142.
25. Armitage JM, Fricker FJ, Kurland G, Hardesty RL, Michaels M, Morita S, Starzl TE, Yousem SA, Jaffe R, Griffith BP. Pediatric lung transplantation. J Thorac Cardiovasc Surg. 1993; 105:337-346.
26. Griffith BP, Bando K, Hardesty RL, Armitage JM, Keenan RJ, Pham SM, Paradis IL, Yousem SA, Komatsu K, Konishi H, Fung JJ, Starzl TE. A prospective randomized trial of FK506 versus cyclosporine after human pulmonary transplantation. Transplant. 1994; 57:848-851.
27. Duncan SR, Grgurich WF, Iacono AT, Burckart GJ, Yousem SA, Paradis IL, Williams PA, Johnson BA, Griffith BP. A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation. Am J Respir Crit Care Med. 1994; 150:146-152.
28. Bailey TC, Trulock EP, Ettinger NA, Storch GA, Cooper JD, Powderly WG. Failure of prophylactic ganciclovir to prevent CMV disease in recipients of lung transplants. J Infect Dis 1992; 165:548-552.
29. Drew WL, Ives D, Lalezari JP, Crumpacker C, Follansbee SE, Spector SA, Benson CA, Friedberg DF, Hubbard L, Stempien MJ, Shadman A, Buhles W. Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. N Engl J Med. 1995; 333:615-620.
30. Zamora MR, Fullerton DA, Campbell DN, Levine S, Diercks MJ, Fisher JH, Badesch DB, Grover FL. Use of cytomegalovirus (CMV) hyperimmune globulin for prevention of CMV disease in CMV-seropositive lung transplant recipients. Transplant Proc. 1994; 26:49-51S.
31. Scott JP, Higenbottam TW, Smyth RL, Whitehead B, Helms P, Fradet G, de Levai M, Wallwork J. Transbronchial biopsies in children after heart-lung transplantation. Pediatrics 1990; 86: 698-702.
32. Kurland G, Noyes BE, Jaffe R, Atlas AB, Armitage J, Orenstein D. Bronchoalveolar lavage and transbronchial biopsy in children following heart-lung and lung transplantation. Chest. 1993; 104:1043-1048.
33. Dummer J, Montero C, Paradis I, Griffith B, Hardesty R, Ho M. Infections in heart-lung recipients. Transplantation. 1986; 41: 725-729.
34. Herve P, Silbert D, Cerrina J, Simonneau G, Dartevelle P, the Paris-Sud Lung Transplant Group. Impairment of bronchial mucociliary clearance in long-term survivors of heart/lung and double lung transplantation. Chest. 1993; 103:59-63.
35. Noyes BE, Paradis IL, Dauber JH. Accessory cell function of blood monocytes and alveolar macrophages after human lung transplantation. Am Rev Respir Dis. 1991; 144:606-611.
36. Hanto D, Frizzera G, Gajl-Peczalska K, Simmons R. Epstein-Barr virus, immunodeficiency, and B-cell lymphoproliferation. Transplant. 1985; 39:461-172.
37. Armitage JM, Kormos RL, Stuart RS, Fricker FJ, Griffith BP, Nalesnik M, Hardesty RL, Dummer JS. Posttransplant lymphoproferative disease in thoracic organ transplant patients: Ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant. 1991; 10:877-886.
38. Sarris GE, Smith JA, Shumway NE, Stinson EB, Oyer PE, Robbins RC, Billingham ME, Theodore J, Moore KA, Reitz BA. Long-term results of combined heart-lung transplantation: The Stanford experience. J Heart Lung Transplant. 1994; 13:940-999.
39. Shapiro RS, Chauvenet A, McGuire W, Pearson A, Craft AW, McGlave P, Filipovich A. Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin [Letter]. N Engl J Med 1988; 318:1334.
40. Starzl TE, Nalesnik MA, Porter KA, Ho M, Iwatsuki S, Griffith BP, Rosenthal JT, Hakala TR, Shaw BW, Hardesty RL. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy. Lancet. 1984; 1:583-587.
41. Trulock EP. Management of lung transplant rejection. Chest. 1993; 103:1566-1576.
42. Yousem S, Berry G, Brunt EM, Chamberlain D, Hruban RH, Sibley RK, Stewart S, Tazelaar HD. A working formation for the standardization of the nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. J Heart Lung Transplant. 1990; 9:593-601.
43. Whitehead B, Rees P, Sorensen K, Bull C, Higenbottam TW, Wallwork J, Fabre J, Elliot M, de Levai M. Incidence of obliterative bronchiolitis after heart-lung transplantation in children. J Heart Lung Transplant. 1993; 12:903-908.
44. Bando K, Paradis IL, Similo S, Konishi H, Komatsu K, Zullo TG, Yousem SA, Close JM, Zeevi A, Duquesnoy RJ, Manzetti J, Keenan RJ, Armitage JM, Hardesty RL, Griffith BP. Obliterative bronchiolitis after lung and heart-lung transplantation. J Thorac Cardiovasc Surg. 1995; 110:4-14.
45. Scott JP, Higenbottam TW, Clelland CA, Stewart S, Smyth RL, McGoldrick JP, Otulana BA, Wallwork J. Natural history of chronic rejection in heart-lung transplant recipients. J Heart Transplant 1990; 9:510-515.
46. Scott JP, Higenbottam TW, Sharples L, Clelland CA, Smyth RL, Stewart S, Wallwork J. Risk factors for obliterative bronchiolitis in heart-lung transplant recipients. Transplantation. 1991; 51: 813-817.
47. Duncan SR, Paradis IL, Yousem SA, Similo SL, Grgurich WF, Williams PA, Dauber JH, Griffith BP, Sequelae of cytomegalovirus pulmonary infections in lung allograft recipients. Am Rev Respir Dis. 1992; 146:1419-1425.
48. Ettinger NA, Bailey TC, Trulock EP, Storch GA, Anderson D, Raab S, Spitznagel EL, Dressler C, Cooper JD. Cytomegalovirus infection and pneumonitis: Impact after isolated lung transplantation. Am Rev Respir Dis. 1993; 147:1017-1023.
49. Paradis I, Yousem S, Griffith B. Airway obstruction and bronchiolitis obliterans after pulmonary transplantation. Clin Chest Med. 1993; 14:751-763.
50. Cooper JD, Billingham M, Egan T, Hertz MI, Higenbottam T, Lynch J, Maurer J, Paradis I, Patterson GA, Smith C, Trulock EP, Vreim C, Yousem S. A working formulation for the standardization of nomenclature for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant. 1993; 12:713-716.
51. Glanville AR, Baldwin JC, Burke CM, Theodore J, Robin ED. Obliterative bronchiolitis after heart-lung transplantation: Apparent arrest by augmented immunosuppression. Ann Intern Med. 1987; 107:300-304.
52. Novick RJ, Kaye MP, Patterson GA, Andréassian B, Klepetko W, Menkis AH, McKenzie FN. Redo lung transplantation: A North American-European experience. J Heart Lung Transplant. 1993; 12:5-16.
53. Hislop A, Odom N, McGregor C, Haworth S. Growth potential of the immature transplanted lung. J Thorac Cardiovasc Surg. 1990; 100:360-370.
54. . Thomas DD, Standaert TA, Anton WR, Jones DR, Godwin JD, Raghu G, Hodson WA, Allen MD. Growth potential of the transplanted lung in the infant primate. Ann Thorac Surg. 1993; 56:1274-1278.
55. Thompson AW, Starzl TE. New immunosuppressive drugs: Mechanistic insights and potential therapeutic advances. Immunol Rev. 1993; 136:71-98.
56. Markus PM, Selvaggi G, Cai X, Fung JJ, Starzl TE. Induction of nor-specific transplant tolerance to skin and cardiac allografts using mixed chimerism in (A + B → A) rats. Cell Transplant. 1994; 2:345-353.
57. Rao AS, Thomson AW, Shapiro R, Starzl TE. Chimerism after whole organ transplantation: Its relationship to graft rejection and tolerance induction. Curr Opin Nephrol Hypertension. 1994; 3:589-595.